Brian Daniels
About Brian Daniels
Brian Daniels serves as the Senior Director of Business Development at Tessera Therapeutics, where he has worked since 2022. With extensive experience in strategic alliances and business development in the biotechnology sector, he has held various leadership roles at notable organizations including CRISPR Therapeutics and the Broad Institute of MIT and Harvard.
Work at Tessera Therapeutics
Brian Daniels serves as the Senior Director of Business Development at Tessera Therapeutics. He has held this position since 2022, contributing to the company's focus on innovative genome engineering technologies. His role involves developing strategic partnerships and alliances that enhance the company's capabilities in gene therapy.
Previous Experience in Biotechnology
Prior to his current role, Brian Daniels worked at several leading biotechnology firms. He was the Director of Strategic Alliances at CRISPR Therapeutics from 2019 to 2021 and served as Senior Director of Business Development at Prime Medicine, Inc. for nine months in 2021-2022. His experience includes managing strategic alliances and business development initiatives.
Education and Expertise
Brian Daniels earned a Ph.D. in Chemical and Biomolecular Engineering and a BS in Chemical Engineering from The Johns Hopkins University. He possesses expertise in genome engineering technology, specifically Gene Writing™, which focuses on integrating therapeutic messages into the genome to treat diseases.
Background in Strategic Alliances
Daniels has a strong background in strategic alliances and operations within the biotechnology sector. He has held multiple director-level positions, including roles at the Broad Institute of MIT and Harvard, where he was involved in strategic alliances and business development for several years.
Experience in Academic and Commercial Settings
Brian Daniels has a diverse professional history that includes both academic and commercial environments. He worked as a Research Scientist at Johns Hopkins University and held a Postdoctoral Fellowship at the National Institutes of Health. His experience bridges scientific research and business development, enabling him to manage biomedical systems and commercial programs effectively.